These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8179352)

  • 61. [Treatment of hypodermatitis of the leg with unsaponifiable extracts of avocado and soya].
    Chaze J
    Phlebologie; 1972; 25(3):315-8. PubMed ID: 4662060
    [No Abstract]   [Full Text] [Related]  

  • 62. [Letter: P-aminopotassium benzoate in the treatment of scleroderma].
    Korting GW
    Hautarzt; 1974 Aug; 25(8):409. PubMed ID: 4424533
    [No Abstract]   [Full Text] [Related]  

  • 63. [Mechanism of the therapeutic efficacy of dimexide in patients with circumscribed scleroderma].
    Sergeev VP
    Vestn Dermatol Venerol; 1983 Jul; (7):64-6. PubMed ID: 6624242
    [No Abstract]   [Full Text] [Related]  

  • 64. Treatment of Generalized Deep Morphea With Everolimus.
    Frumholtz L; Roux J; Bagot M; Rybojad M; Bouaziz JD
    JAMA Dermatol; 2016 Oct; 152(10):1170-1172. PubMed ID: 27439068
    [No Abstract]   [Full Text] [Related]  

  • 65. [Experience with the treatment of juvenile hepatitis using prednisone].
    Morávková J
    Cesk Pediatr; 1966 Oct; 21(10):876-9. PubMed ID: 5977479
    [No Abstract]   [Full Text] [Related]  

  • 66. [Treatment of some sclerosing processes with uropancreozymin].
    Hodác V; Svatos A
    Cesk Dermatol; 1971 Apr; 46(2):83-6. PubMed ID: 5564727
    [No Abstract]   [Full Text] [Related]  

  • 67. [Prednisone in the treatment of Gibert's pityriasis].
    Kalbarczyk K; Gutowski W
    Wiad Lek; 1972 Apr; 25(7):627-8. PubMed ID: 5047081
    [No Abstract]   [Full Text] [Related]  

  • 68. Biomarkers in skin autoimmunity-An update on localised scleroderma.
    Hernández-Bustos A; Bolos B; Astakhova K
    Skin Health Dis; 2024 Apr; 4(2):e335. PubMed ID: 38577035
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Juvenile localized scleroderma].
    Strauss T; Günther C; Brück N
    Dermatologie (Heidelb); 2024 Mar; 75(3):208-213. PubMed ID: 38240812
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Morphea: The 2023 update.
    Papara C; De Luca DA; Bieber K; Vorobyev A; Ludwig RJ
    Front Med (Lausanne); 2023; 10():1108623. PubMed ID: 36860340
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Therapeutic and Reconstructive Management Options in Scleroderma (Morphea) en Coup de Sabre in Children and Adults. A Systematic Literature Review.
    Ulc E; Rudnicka L; Waśkiel-Burnat A; Warszawik-Hendzel O; Niemczyk A; Olszewska M
    J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640533
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Update on Management of Morphea (Localized Scleroderma) in Children.
    George R; George A; Kumar TS
    Indian Dermatol Online J; 2020; 11(2):135-145. PubMed ID: 32477969
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Overview of Juvenile localized scleroderma and its management.
    Li SC; Zheng RJ
    World J Pediatr; 2020 Feb; 16(1):5-18. PubMed ID: 31786801
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Consensus-based recommendations for the management of juvenile localised scleroderma.
    Zulian F; Culpo R; Sperotto F; Anton J; Avcin T; Baildam EM; Boros C; Chaitow J; Constantin T; Kasapcopur O; Knupp Feitosa de Oliveira S; Pilkington CA; Russo R; Toplak N; van Royen A; Saad Magalhães C; Vastert SJ; Wulffraat NM; Foeldvari I
    Ann Rheum Dis; 2019 Aug; 78(8):1019-1024. PubMed ID: 30826775
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.
    Ferreli C; Gasparini G; Parodi A; Cozzani E; Rongioletti F; Atzori L
    Clin Rev Allergy Immunol; 2017 Dec; 53(3):306-336. PubMed ID: 28712039
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Morphea and Eosinophilic Fasciitis: An Update.
    Mertens JS; Seyger MMB; Thurlings RM; Radstake TRDJ; de Jong EMGJ
    Am J Clin Dermatol; 2017 Aug; 18(4):491-512. PubMed ID: 28303481
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Corticosteroids in Myositis and Scleroderma.
    Postolova A; Chen JK; Chung L
    Rheum Dis Clin North Am; 2016 Feb; 42(1):103-18, ix. PubMed ID: 26611554
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Systemic sclerosis and localized scleroderma--current concepts and novel targets for therapy.
    Distler O; Cozzio A
    Semin Immunopathol; 2016 Jan; 38(1):87-95. PubMed ID: 26577237
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Localized scleroderma: clinical spectrum and therapeutic update.
    Careta MF; Romiti R
    An Bras Dermatol; 2015; 90(1):62-73. PubMed ID: 25672301
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma.
    Li SC; Torok KS; Pope E; Dedeoglu F; Hong S; Jacobe HT; Rabinovich CE; Laxer RM; Higgins GC; Ferguson PJ; Lasky A; Baszis K; Becker M; Campillo S; Cartwright V; Cidon M; Inman CJ; Jerath R; O'Neil KM; Vora S; Zeft A; Wallace CA; Ilowite NT; Fuhlbrigge RC;
    Arthritis Care Res (Hoboken); 2012 Aug; 64(8):1175-85. PubMed ID: 22505322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.